Lloyd A. Rowland, VP, Chief Compliance Officer at AMYLIN PHARMACEUTICALS INC (AMLN), sold 8,000 shares at $22.83 ($189K) on 2012-03-28, disclosed to the SEC on 2012-03-29.
Scheduled sale ($189k) by VP, Chief Compliance Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $22.83 | 5,000 | $114K | 60.3% |
| 2 | $25.00 | 3,000 | $75K | 39.7% |
| Total | $23.64 avg | 8,000 | $189K | 100% |
| Filing → |
| CTMX | SELL | 2024-03-21 | $11K | — | Filing → |
| CTMX | SELL | 2023-12-22 | $6K | — | Filing → |
| CTMX | SELL | 2023-09-22 | $7K | — | Filing → |